145 related articles for article (PubMed ID: 10799818)
1. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system.
Yamamura S; Gotoh H; Sakamoto Y; Momose Y
Eur J Pharm Biopharm; 2000 May; 49(3):259-65. PubMed ID: 10799818
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical properties of amorphous salt of cimetidine and diflunisal system.
Yamamura S; Gotoh H; Sakamoto Y; Momose Y
Int J Pharm; 2002 Jul; 241(2):213-21. PubMed ID: 12100849
[TBL] [Abstract][Full Text] [Related]
3. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
[TBL] [Abstract][Full Text] [Related]
4. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
5. [The development of co-amorphous drug systems].
Yao J; Shi NQ; Wang XL
Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
[TBL] [Abstract][Full Text] [Related]
6. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
7. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin.
Ojarinta R; Heikkinen AT; Sievänen E; Laitinen R
Eur J Pharm Biopharm; 2017 Mar; 112():85-95. PubMed ID: 27888143
[TBL] [Abstract][Full Text] [Related]
8. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cimetidine-piroxicam coprecipitate interaction using experimental studies and molecular dynamic simulations.
Tantishaiyakul V; Suknuntha K; Vao-Soongnern V
AAPS PharmSciTech; 2010 Jun; 11(2):952-8. PubMed ID: 20512435
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
[TBL] [Abstract][Full Text] [Related]
11. Melt Extrusion of High-Dose Co-Amorphous Drug-Drug Combinations : Theme: Formulation and Manufacturing of Solid Dosage Forms Guest Editors: Tony Zhou and Tonglei Li.
Arnfast L; Kamruzzaman M; Löbmann K; Aho J; Baldursdottir S; Rades T; Rantanen J
Pharm Res; 2017 Dec; 34(12):2689-2697. PubMed ID: 28929263
[TBL] [Abstract][Full Text] [Related]
12. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
[TBL] [Abstract][Full Text] [Related]
13. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation.
Allesø M; Chieng N; Rehder S; Rantanen J; Rades T; Aaltonen J
J Control Release; 2009 May; 136(1):45-53. PubMed ID: 19331842
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure transformations and dissolution studies of cimetidine-piroxicam coprecipitates and physical mixtures.
Tantishaiyakul V; Songkro S; Suknuntha K; Permkum P; Pipatwarakul P
AAPS PharmSciTech; 2009; 10(3):789-95. PubMed ID: 19521782
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of two poor water soluble drugs - nanoporous ZnO solid dispersions and the mechanism of drug dissolution improvement].
Gao B; Sun CS; Zhi ZZ; Wang Y; Chang D; Wang SL; Jiang TY
Yao Xue Xue Bao; 2011 Nov; 46(11):1399-407. PubMed ID: 22260037
[TBL] [Abstract][Full Text] [Related]
16. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
[TBL] [Abstract][Full Text] [Related]
17. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
18. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
[TBL] [Abstract][Full Text] [Related]
19. Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: A strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis.
Chen X; Li D; Zhang H; Duan Y; Huang Y
Int J Pharm; 2021 Sep; 606():120894. PubMed ID: 34280485
[TBL] [Abstract][Full Text] [Related]
20. Effects of Heat Treatment on Indomethacin-Cimetidine Mixture; Investigation of Drug-Drug Interaction Using Singular Value Decomposition in FTIR Spectroscopy.
Otsuka Y; Kuwashima W; Tanaka Y; Yamaki Y; Shimada Y; Goto S
J Pharm Sci; 2021 Mar; 110(3):1142-1147. PubMed ID: 33035536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
